Concepedia
Statistics
Publications
33
Citations
1.1K
H-Index
22
Active since
2012
Affiliations
Tianjin University of Science and Technology(Current)
Dana-Farber Cancer Institute
State Key Laboratory of Food Nutrition and Safety
Kaohsiung Medical University
Institute for Fermentation
Yuyin Li is an author at Tianjin University of Science and Technology specializing in medicine, cell biology, and pharmacology.
Top concepts
MedicineCell BiologyPharmacologyCell DeathImmunologyCell SignalingDrug DiscoveryApoptosisCancer ResearchNatural Sciences
Publications per year
2012–2022
Attenuation of p38-Mediated miR-1/133 Expression Facilitates Myoblast Proliferation during the Early Stage of Muscle Regeneration
Duo Zhang, Xihua Li, Chuchu Chen et al. · PLoS ONE · 2012 · 95 citations · Full text
Regenerative Medicine, Mechanobiology, P38 Activity +14
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma
Liang Lin, Shih‐Feng Cho, Lijie Xing et al. · Leukemia · 2020 · 85 citations · Full text
Hematological Malignancy, Cancer Immunosurveillance, Preclinical Evaluation +13
Discovery of Myricetin as a Potent Inhibitor of Human Flap Endonuclease 1, Which Potentially Can Be Used as Sensitizing Agent against HT-29 Human Colon Cancer Cells
Long Ma, Xiuqi Cao, Haiyue Wang et al. · Journal of Agricultural and Food Chemistry · 2019 · 71 citations · Full text
The immunomodulatory drugs lenalidomide and pomalidomide enhance the potency of AMG 701 in multiple myeloma preclinical models
Shih‐Feng Cho, Liang Lin, Lijie Xing et al. · Blood Advances · 2020 · 69 citations · Full text
A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma
Lijie Xing, Liang Lin, Tengteng Yu et al. · Leukemia · 2020 · 60 citations · Full text
Hematological Malignancy, Atm/atr/wee1 Inhibitors, Medicine +8
1–5 of 33